{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Dasatinib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Dasatinib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Dasatinib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "dasatinib",
    "trial_2_text": "Dasatinib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Dasatinib Supplement: 60 participants will take Dasatinib 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Dasatinib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Dasatinib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.39298877120018005,
      "123": 0.25299760699272156,
      "21": 0.2502458691596985,
      "64": 0.2331995666027069,
      "78": 0.20657071471214294,
      "17": 0.18256482481956482,
      "20": 0.1650490164756775,
      "67": 0.16018451750278473,
      "189": 0.15610836446285248,
      "49": 0.15136320888996124,
      "121": 0.1476532369852066,
      "173": 0.14401985704898834,
      "228": 0.14215527474880219,
      "177": 0.13966050744056702,
      "68": 0.1388600468635559,
      "46": 0.1383713334798813,
      "188": 0.13014240562915802,
      "101": 0.1261216253042221,
      "126": 0.12440326809883118,
      "9": 0.12170826643705368,
      "200": 0.11301261186599731,
      "179": 0.10791532695293427,
      "29": 0.10751054435968399,
      "136": 0.10484472662210464,
      "37": 0.10237130522727966,
      "114": 0.1001373827457428,
      "85": 0.0963507816195488,
      "14": 0.0957304835319519,
      "142": 0.09520511329174042,
      "104": 0.09454622119665146,
      "2": 0.09440173208713531,
      "191": 0.09428375959396362,
      "350": 0.09180742502212524,
      "18": 0.09135621041059494,
      "79": 0.08807868510484695,
      "243": 0.08387921005487442,
      "76": 0.08055835962295532,
      "257": 0.0804557204246521,
      "77": 0.07889263331890106,
      "147": 0.07885532826185226,
      "194": 0.07780612260103226,
      "61": 0.07776288688182831,
      "193": 0.07639462500810623,
      "28": 0.07544767111539841,
      "96": 0.07533349841833115,
      "122": 0.07383344322443008,
      "239": 0.07382582873106003,
      "261": 0.07259637117385864,
      "27": 0.07111186534166336,
      "72": 0.0708625540137291,
      "249": 0.0694926530122757,
      "5": 0.06689184904098511,
      "246": 0.06630565971136093,
      "253": 0.06626272201538086,
      "86": 0.06606250256299973,
      "212": 0.0655210092663765,
      "347": 0.06478007882833481,
      "356": 0.06355950236320496,
      "282": 0.0629585012793541,
      "4": 0.06224948540329933,
      "211": 0.06159718334674835,
      "396": 0.06117171049118042,
      "100": 0.06081079691648483,
      "151": 0.060513418167829514,
      "130": 0.05971026420593262,
      "180": 0.05925619229674339,
      "355": 0.05815922096371651,
      "35": 0.05800546333193779,
      "288": 0.05762222036719322,
      "154": 0.05649460852146149,
      "255": 0.055447135120630264,
      "69": 0.05338660255074501,
      "213": 0.053292375057935715,
      "269": 0.052955713123083115,
      "82": 0.05215269699692726,
      "155": 0.05045461654663086,
      "144": 0.049991633743047714,
      "441": 0.04966602846980095,
      "102": 0.04966452345252037,
      "234": 0.04907732829451561,
      "36": 0.04859841987490654,
      "339": 0.04840930923819542,
      "30": 0.04810073599219322,
      "22": 0.047689348459243774,
      "116": 0.047220077365636826,
      "38": 0.047182902693748474,
      "382": 0.047028910368680954,
      "139": 0.04681512713432312,
      "131": 0.046522997319698334,
      "135": 0.04631814733147621,
      "33": 0.04424221068620682,
      "186": 0.04419400542974472,
      "503": 0.043826937675476074,
      "254": 0.042313072830438614,
      "286": 0.04224637523293495,
      "31": 0.04194418340921402,
      "263": 0.041722919791936874,
      "276": 0.04149789735674858,
      "133": 0.04111994802951813,
      "1": 0.040533874183893204
    },
    "trial_2_ae": {
      "87": 0.39298877120018005,
      "123": 0.25299760699272156,
      "21": 0.2502458691596985,
      "64": 0.2331995666027069,
      "78": 0.20657071471214294,
      "17": 0.18256482481956482,
      "20": 0.1650490164756775,
      "67": 0.16018451750278473,
      "189": 0.15610836446285248,
      "49": 0.15136320888996124,
      "121": 0.1476532369852066,
      "173": 0.14401985704898834,
      "228": 0.14215527474880219,
      "177": 0.13966050744056702,
      "68": 0.1388600468635559,
      "46": 0.1383713334798813,
      "188": 0.13014240562915802,
      "101": 0.1261216253042221,
      "126": 0.12440326809883118,
      "9": 0.12170826643705368,
      "200": 0.11301261186599731,
      "179": 0.10791532695293427,
      "29": 0.10751054435968399,
      "136": 0.10484472662210464,
      "37": 0.10237130522727966,
      "114": 0.1001373827457428,
      "85": 0.0963507816195488,
      "14": 0.0957304835319519,
      "142": 0.09520511329174042,
      "104": 0.09454622119665146,
      "2": 0.09440173208713531,
      "191": 0.09428375959396362,
      "350": 0.09180742502212524,
      "18": 0.09135621041059494,
      "79": 0.08807868510484695,
      "243": 0.08387921005487442,
      "76": 0.08055835962295532,
      "257": 0.0804557204246521,
      "77": 0.07889263331890106,
      "147": 0.07885532826185226,
      "194": 0.07780612260103226,
      "61": 0.07776288688182831,
      "193": 0.07639462500810623,
      "28": 0.07544767111539841,
      "96": 0.07533349841833115,
      "122": 0.07383344322443008,
      "239": 0.07382582873106003,
      "261": 0.07259637117385864,
      "27": 0.07111186534166336,
      "72": 0.0708625540137291,
      "249": 0.0694926530122757,
      "5": 0.06689184904098511,
      "246": 0.06630565971136093,
      "253": 0.06626272201538086,
      "86": 0.06606250256299973,
      "212": 0.0655210092663765,
      "347": 0.06478007882833481,
      "356": 0.06355950236320496,
      "282": 0.0629585012793541,
      "4": 0.06224948540329933,
      "211": 0.06159718334674835,
      "396": 0.06117171049118042,
      "100": 0.06081079691648483,
      "151": 0.060513418167829514,
      "130": 0.05971026420593262,
      "180": 0.05925619229674339,
      "355": 0.05815922096371651,
      "35": 0.05800546333193779,
      "288": 0.05762222036719322,
      "154": 0.05649460852146149,
      "255": 0.055447135120630264,
      "69": 0.05338660255074501,
      "213": 0.053292375057935715,
      "269": 0.052955713123083115,
      "82": 0.05215269699692726,
      "155": 0.05045461654663086,
      "144": 0.049991633743047714,
      "441": 0.04966602846980095,
      "102": 0.04966452345252037,
      "234": 0.04907732829451561,
      "36": 0.04859841987490654,
      "339": 0.04840930923819542,
      "30": 0.04810073599219322,
      "22": 0.047689348459243774,
      "116": 0.047220077365636826,
      "38": 0.047182902693748474,
      "382": 0.047028910368680954,
      "139": 0.04681512713432312,
      "131": 0.046522997319698334,
      "135": 0.04631814733147621,
      "33": 0.04424221068620682,
      "186": 0.04419400542974472,
      "503": 0.043826937675476074,
      "254": 0.042313072830438614,
      "286": 0.04224637523293495,
      "31": 0.04194418340921402,
      "263": 0.041722919791936874,
      "276": 0.04149789735674858,
      "133": 0.04111994802951813,
      "1": 0.040533874183893204
    }
  },
  "safety": {
    "trial_1_safety": 0.5178184509277344,
    "trial_2_safety": 0.5178184509277344
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.47422266006469727
  }
}